Week 4: Neoplasms of kidney, urinary tract, and prostate Flashcards

1
Q

Angiomyolipoms

A
  • most clinically significant benign tumor of kidney, hamartomatous
  • associated with tuberous sclerosis
  • sporadic: unilateral, solitary, seen in middle aged women
  • well circumscribed, usually in renal cortex
  • diagnosed on CT scan
  • has mature fat, abnormal blood vessels, and spindle cell proliferation that resembles smooth muscle
  • can bleed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Oncocytoma

A
  • benign epithelial tumor
  • micro:composed of large cells with small uniform nuclei and abundant eosinophilic cytoplasm
  • solid enhancing mass, usually found incidentally
  • indistinguishable from RCC
  • gross: encapsulated, mahogany brown, central stellate scar
  • no yellow, necrosis, hemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Incidence and epidemiology of renal cell carcinoma

A

-most common malignant parenchymal tumor in adult kidney
-30,000 cases/year in US
-95% sporadic: risk factors are smoking, obesity, uncontrolled HTN
5% familial: assoc with Von Hippel-Lindau disease. inactivation of VHL gene on chrom 3 (tumor suppressor gene)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of renal cell carcinoma

A
  • clear cell carcinoma (75%)
  • chromophil papillary type- 15%
  • chromophobe type -5%
  • collecting duct- 1%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Work up of a renal mass.

A
  • IVP (not really used) or renal ultrasound
  • CT scan with contrast required
  • chest x-ray and bone scan to look for metastatic disease
  • usually DON’t biopsy the lesion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical presentation of renal cell carcinoma

A
  • Classic triad: hematuria, flank plain, mass (however, all three rarely found together in patients
  • have vague non specific abdominal plain, GI complaints, weight loss
  • paraneoplastic syndromes (e.g. release of renin, EPO, PTHrP, ACTH)–>polycythemia, hypercalcemia, Cushing, hepatic dysfunction, HTN, anemia, fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Spread of renal cell carcinoma

A
  • 30% are metastatic at initial presentation
  • spread through lymphatics, port system, blood, direct extension
  • propensity to grow into renal vein and vena cava as a tumor thrombus
  • distant metastasis to lung, bones, brain, adrenal, liver,
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gross pathology of renal cell carcinoma (renal adenocarcinoma)

A
  • all types look similar at gross level
  • usually solitary and unilateral
  • von Hippel Lindau: multiple and bilateral
  • occur in cortex, large, round, commonly with fibrous capsule
  • variegated appearance with cut surface having yellow, brown, white and gray areas
  • hemorrhage necrosis, and fibrosis are common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Microscopic features of clear cell carcinoma

A
  • 75% of all renal carcinomas
  • large cells with clear cytoplasm arranged in solid nests or alveolar structures, separated by prominent vascular network
  • divided into 4 grades
    1. large cells, uniform nuclei, 2. larger nuclei 3. large, pleomorphic nuclei, prominent nucleoli, 4. lose architectural features, more spindle shaped and pleomorphic. resembles sarcoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Microscopic features of papillary carcinoma

A
  • papillary and tubular growth pattern, smaller cells without clear cytoplasm
  • well differentiated and low grade
  • high grades uncommon
  • mutation of MET gene localized in chromosome 7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Staging of renal cell carcinoma

A

-best prognostic indicator
T1: limited to kidney, 7mm
T3: into major veins: I or peripnephric invasion
T4: invasion to adrenal or into surround structures
N1-1: nodal metastases
M1: distant metastates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of renal cell carcinoma

A
  • only curative treatment is surgery
  • chemo and radiation not effective
  • immunotherapy such as Il-2 or INF used for metastatic disease
  • anti VEGF type agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Incidence of Wilm’s Tumor

A
  • most common tumor of kidney in childhood

- ages 2-10 yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical presentation of Wilm’s Tumor

A
  • usually presents as palpable mass
  • can cause hematuria, pain, failure to thrive
  • often unilateral
  • sensitive to chemo and radiation
  • increased risk if associated with WAGR syndrome: predisposed to Wilm’s, Aniridia, genitourinary abnormalities, retardation
  • associated with WT-1 mutations, Beckwith Weidaman
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gross pathology of Wilm’s Tumor

A

-well delineated, globular, large, grayish white, with pressure atrophy of surround kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Microscopic features of Wilm’s Tumor

A
  • blastema (embryonic cells), primitive glomerular tubules, stroma cells
  • small ovoid cells with hyper chromatic nuclei and scant cytoplasm
  • necrosis and high mitotic rate in anapestic tumors
  • grades I: well differentiated, II: intermediate-primitive tubules, III: undifferentiated, resembles undiff. nephroblast
17
Q

Treatment of Wilm’s Tumors

A
  • combo treatments: nephrectomy, chemotherapy, radiation
  • stage, grade, cell type are predictors
  • high survival rate
18
Q

Incidence and etiology of urothelial carcinoma

A
  • can occur anywhere from renal calyces to urethra
  • mostly in bladder
  • risk factors: cigarette smoke, Schistosomiasis, azo dyes, l
19
Q

Symptoms of urothelial carcinoma.

A
  • gross or microscopic hematuria that is PAINLESS
  • painless hematuria in patient >40 yo. think Bladder Cancer
  • occasionally with dysuria or frequency/urgency
20
Q

Histological features of urothelial carcinoma.

A
  • usually transitional cell carcinomas
  • Two types: papillary or flat
  • normal urothelium is 7 layers thick or less
    1. Low grade: includes papiloma, grade I and II: papillary structures linked with thickened transitional epithelial cells. Normal to moderate cytologic abnormalities
    2. High grade: includes grade III, carcinoma in situ, and some grade II. Associated with loss of heterozygocity and mutations in p53 tumor suppressor gene mutations. CIS are flat lesions
21
Q

Behavior and treatment of urothelial carcinoma

A
  1. low grade -80% are superficial and low grade
    - tends to recur
    - multifocal
    - invasion and metastasis uncommon
    rx: surgical resection
  2. high grade
    - invade early through BM into lamina propia and into muscle wall
    - metastasize
    rx: radical cystectomy
22
Q

Incidence of adenocarcinoma of the prostate. Diagnosed how?

A
  • most common cancer in men
  • 30% of patients over 70 have occult prostate cancers at autopsy
  • diagnosed by transrectal biopsy of the prostate. Multiple biopsies taken by needle from different areas of the prostate
23
Q

Symptoms of prostate carcinoma

A
  • most have no symptoms, detected as elevation of serum PSA level or nodule on examination
  • symptoms late in course of cancer: obstructive voiding complaints, back pain, bone pain (metastases)
24
Q

histological features of prostate carcinoma

A
  • small irregular infiltrative glands (normal prostate has large glands with two layer epithelium-basal cells)
  • single layer of enlarged cells
  • no basal cells; k903 negative (normal prostate has basal cells positive for k903 and p63)
  • large nuclei with prominent nucleoli
  • perineural invasion
  • luminal crystals mucin
  • express new antigens- racemase
25
Q

Prognosis and treatment of prostate cancer.

A
  • low grade localized prostate cancer is often cured with treatment. May take up to 20 years to cause symptoms or spread
  • high grade cancers with bone metastases have poor prognosis
  • hormone therapy is cornerstone of treating advanced disease, i.e. blocking testosterone